Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibrin, also known as Factor Ia, is a fibrous, non-globular protein that plays a crucial role in blood clotting (hemostasis). It is formed through the conversion of fibrinogen, a soluble plasma protein, by the action of the protease enzyme thrombin. This conversion and subsequent polymerization of fibrin is essential for wound healing and preventing excessive blood loss. Fibrin is the major component of blood clots, forming a mesh atop platelet plugs at wound sites to prevent blood loss. It also provides a scaffold for cell migration and tissue repair during the wound healing process. Abnormalities in fibrin formation or degradation are associated with various pathological conditions, including thrombosis, hemorrhagic disorders, cancer, and cardiovascular disease. Fibrin degradation products (FDPs), particularly D-dimer, are measured to detect conditions involving abnormal clot formation or dissolution.
Modulating fibrinogen levels or targeting fibrin-dependent interactions
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibrin (Factor Ia).